Protagonist Therapeutics
PTGX
#3620
Rank
NZ$4.59 B
Marketcap
$74.93
Share price
-2.84%
Change (1 day)
73.06%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$4.39

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.48. In 2022 the company made an earnings per share (EPS) of -$4.34 an increase over its 2021 EPS that were of -$4.51.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.391.09%
2022-$4.34-3.7%
2021-$4.5135%
2020-$3.34-33.33%
2019-$5.0174.42%
2018-$2.87-20.74%
2017-$3.63-45.64%
2016-$6.6757.3%
2015-$4.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.64-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA